Prodigy Health is a national distributor of specialty pharmaceuticals including such products as plasma derivatives, recombinant protein therapies and other high-touch or sensitive therapies. Since the company's inception in 2001, Prodigy has concentrated specifically in hemophilia and the bleeding disorders space. Now Prodigy has expanded its portfolio with specialty products for rare disease states, such as Hereditary Angioedema, enzyme therapies, reversal agents and anti-venom. The company is licensed in all 50 states and have multiple redundant distribution hubs, which are Verified-Accredited Wholesale Distributors (VAWD), accredited by the National Board of Pharmacy. Prodigy is fully compliant with DQSA/DSCSA regulations providing a secure supply chain for the customers they serve. Click here for more information.